| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |